Patents by Inventor Ashley Ng

Ashley Ng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240240187
    Abstract: The invention relates to a Matriptase-2 (MT2) and/or TMPRSS6 inhibitor for the prevention, decrease of the risk of suffering from or treatment of a myeloproliferative disorder.
    Type: Application
    Filed: April 26, 2022
    Publication date: July 18, 2024
    Inventors: Cavan Bennett, Sant-Rayn Pasricha, Ashley Ng, Sibylle Dames, Ute Schaeper
  • Publication number: 20190347599
    Abstract: Systems and methods are provided for routing support tickets. The system may be configured to receive a support ticket. Metadata information corresponding to the support ticket may be obtained by the system. The metadata information may indicate at least one component associated with the support ticket. Based on the metadata information corresponding to the support ticket and respective attributes associated with the first entity, the system may be configured to assign the support ticket to at least a first entity. Assigning the support ticket to at least the first entity may include providing a list of one or more entities that are eligible for assignment, determining a user selection of the first entity through an interface, and storing a record of the support ticket being assigned to the first entity.
    Type: Application
    Filed: May 29, 2018
    Publication date: November 14, 2019
    Inventors: Zachary Fry, Mohammad Bukhari, Ashley Ng, Cody Moore, Christopher Tschinkel, Nathanial Newman, Roman Myers, Yiwei Gao, Zachary Alberico
  • Patent number: 6870031
    Abstract: The present invention is directed to a novel haemopoietin receptor or a derivative thereof and to genetic sequences encoding same. The receptor molecule and its derivatives and the genetic sequences encoding same of the present invention are useful in the development of a wide range of agonists, antagonists, therapeutics and diagnostic reagents based on ligand interaction with its receptor. The present invention particularly relates to a receptor for leptin.
    Type: Grant
    Filed: December 7, 2001
    Date of Patent: March 22, 2005
    Assignee: Amrad Operations Pty. Ltd.
    Inventors: Douglas James Hilton, Tracy Willson, Timothy Gainsford, Warren S Alexander, Donald Metcalf, Ashley Ng, Nicos A Nicola
  • Publication number: 20050004015
    Abstract: The present invention is directed to a novel haemopoietin receptor or a derivative thereof and to genetic sequences encoding same. The receptor molecule and its derivatives and the genetic sequences encoding same of the present invention are useful in the development of a wide range of agonists, antagonists, therapeutics and diagnostic reagents based on ligand interaction with its receptor. The present invention particularly relates to a receptor for leptin.
    Type: Application
    Filed: December 7, 2001
    Publication date: January 6, 2005
    Inventors: Douglas Hilton, Tracy Willson, Timothy Gainsford, Warren Alexander, Donald Metcalf, Ashley Ng, Nicos Nicola
  • Patent number: 6414128
    Abstract: The present invention is directed to a novel haemopoietin receptor or a derivative thereof and to genetic sequences encoding same. The receptor molecule and its derivatives and the genetic sequences encoding same of the present invention are useful in the development of a wide range of agonists, antagonists, therapeutics and diagnostic reagents based on ligand interaction with its receptor. The present invention particularly relates to a receptor for leptin.
    Type: Grant
    Filed: September 17, 1998
    Date of Patent: July 2, 2002
    Assignee: Amrad Operations Pty. Ltd.
    Inventors: Douglas James Hilton, Tracy Willson, Timothy Gainsford, Warren S Alexander, Donald Metcalf, Ashley Ng, Nicos A Nicola